Skip to main content
class com.aha.ucm.component.cis.TagListPageData=[,docNativeURL=null,docName=UCM_499732,docStatus=RELEASED,dOutDate=null,docSSFileName=UCM_499732_Free-Article-Exchange-February-2018--American-Journal-of-Nephrology.jsp,docTitle=Free Article Exchange | February 2018 | American Journal of Nephrology,xWebsites=professional,dDocAuthor=stacy.ragsdale,xNextReviewDate=09/22/2016 5:42 PM,xTier1=36,xFeaturedItem=No,xElectronicRegistration=No,UserLocale=null,xSubCategory=,dpEvent=null,xComments=The February 2018 announcement of the free access articles from the American Journal of Nephrology.,NoHttpHeaders=null,UserTimeZone=null,xRegionDefinition=GENERIC_RD_COL_1,xVideoRenditions=,xSnippetItem=,xNotes=,UserDateFormat=null,encodeDocUrl=null,isDocProfileDone=null,xKeywords=kidney; hypertension; high blood pressure; chronic kidney disease, kidney dysfunction,xTier2=,refreshSubMonikers=null,xEditorStepReassignedUsers=null,xLinkTextToDisplay=,dDocAccount=WCM/SOP/SPUB,xEndDateTime=null,xClbraAliasList=null,ClientEncoding=null,xCpdIsLocked=0,xUsageRightsDate=null,xModifyDate=06/06/2018 12:19 PM,xTier3=,xEventDate=null,dSubscriptionType=null,xCopyright=No,xPackagedConversions=,dSubscriptionAlias=null,xStorageRule=,dpName=null,xDepartment=Science Operations,dStatus=RELEASED,dPublishType=,xCopyrightDetails=,xSubType=64,isDocProfileUsed=null,xWebsiteObjectType=Data File,xWebFlag=,xSeeAlsoLinks=,xClbraUserList=null,xPartitionId=,xCpdIsTemplateEnabled=0,xLinkWebAddress=,xDontShowInListsForWebsites=,xStartDateTime=null,dInDate=06/06/2018 12:16 PM,xWebsiteSection=professional:1463,dDocName=UCM_499732,dpAction=null,dRevLabel=3,dSecurityGroup=AHAMAH-Public,xCategory=,refreshMonikers=null,xDamConversionType=,dDocFormats=null,xAssociatedImage=,dDocType=SingleColumn,xBusinessOwner=Business Owner,xUploadDate=null,xDiscussionCount=0,xMainFlowEntryCriteria=True,xItemInformation=,xUsageRights=,xDiscussionType=N/A,xRecipeTaxonomy=,dSubscriptionID=null,dOriginalName=UCM_499732.xml,xProfileTrigger=SingleColumn,dLocation=,dRevisionID=3,dPublishState=,dReleaseState=Y,xTrashDeleter=null,dMessage=,dWebExtension=xml,dExtension=xml,dProcessingState=Y,xTrashDeleteName=null,dIsCheckedOut=0,xForceFolderSecurity=null,dRevClassID=499732,dIsPrimary=1,dFileSize=10973,dIndexerState=,dFlag1=,xviaAddNewContentService=,dIsWebFormat=0,xCollectionID=null,dRevRank=0,xReadOnly=null,dCheckoutUser=,dFormat=Application/xml,dWorkflowState=,dDocID=1847044,dRendition2=,dRendition1=,xInhibitUpdate=null,dReleaseDate=06/06/2018 12:19 PM,xTrashDeleteLoc=null,dCreateDate=06/06/2018 12:17 PM,xHidden=null,labelTier1=ScienceNews,labelTier2=,labelTier3=,labelTier4=,mobileNavURL=DEFAULT2_VALUE_FROM_getDataForAdvanceSearch,xContactPhoneNumber=,xContactEmailAddress=,xContactName=,xATGRolesDisciplines=,xPublishDate=03/16/2018 5:00 AM,xRobotParameter=,xCommunities=1006-2023,xMembershipLevel=,rsCalories=null,rsSodium=null,rsRecipeTaxonomy=null,rsServings=null,rsTotalTime=null,rsTotalFat=null,rsTotalCarbs=null,rsFeaturedImage=null,xDisplayComments=

American Journal of Nephrology
Free-Access Articles
(Vol. 46, issue 6, 2017 and Vol. 47, issue 1, 2018)

Special service from Karger Publishers for the readers of Hypertension


Uremic Pruritus: An Itch with Ominous Consequences
M.J. Germain
Am J Nephrol 2017;46:448–449

Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy
J.J. Neumiller, C.M. Rhee, K. Kalantar-Zadeh
Am J Nephrol 2017;46:459–461

Periostin: The Missing Link to Attenuate Kidney Fibrosis
N. Prakoura, C. Chatziantoniou
Am J Nephrol 2017;46:498–500

Glycemic Control Assessment in the Dialysis Patient: Is Glycated Albumin the Answer?
M.E. Molitch
 Am J Nephrol 2018;47:18–20

Original Reports: Patient-Oriented, Translational Research

Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients
R. Kido, T. Akizawa, M. Fukagawa, Y. Onishi, T. Yamaguchi, S. Fukuhara
Am J Nephrol 2017;46:439–447

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
M.J. Jardine, K.W. Mahaffey, B. Neal, R. Agarwal, G.L. Bakris, B.M. Brenner, S. Bull, C.P. Cannon, D.M. Charytan, D. de Zeeuw, R. Edwards, T. Greene, H.J.L. Heerspink, A. Levin, C. Pollock, D.C. Wheeler, J. Xie, H. Zhang, B. Zinman, M. Desai, V. Perkovic, on behalf of the CREDENCE study investigators
Am J Nephrol 2017;46:462–472

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
M.P. Chin, G.L. Bakris, G.A. Block, G.M. Chertow, A. Goldsberry, L.A. Inker, H.J.L. Heerspink, M. O’Grady, P.E. Pergola, C. Wanner, D.G. Warnock, C.J. Meyer
Am J Nephrol 2018;47:40–47

Original Reports: Laboratory Investigation

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
F.R. Mc Causland, B. Claggett, M.A. Pfeffer, E.A. Burdmann, K.-U. Eckardt, A.S. Levey, J.J.V. McMurray, G. Remuzzi, A.K. Singh, S.D. Solomon, R.D. Toto, P. Parfrey
Am J Nephrol 2017;46:488–497

Experimental Inhibition of Periostin Attenuates Kidney Fibrosis
J.H. Hwang, S.H. Yang, Y.C. Kim, J.H. Kim, J.N. An, K.C. Moon, Y.K. Oh, J.Y. Park, D.K. Kim, Y.S. Kim, C.S. Lim, J.P. Lee
Am J Nephrol 2017;46:501–517

Novel Research Findings

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus
V.S. Mathur, J. Kumar, P.W. Crawford, H. Hait, T. Sciascia, for the TR02 Study Investigators
Am J Nephrol 2017;46:450–458

Combination Cyclophosphamide/Glucocorticoids Provide Better Tolerability and Outcomes versus Glucocorticoids Alone in Patients with Sjogren’s Associated Chronic Interstitial Nephritis
Y. Shen, J. Xie, L. Lin, X. Li, P. Shen, X. Pan, H. Ren, N. Chen
Am J Nephrol 2017;46:473–480

Science News Commentaries
View All Science News Commentaries

AHA's Statement on the Safety Profile of Statins: Big Benefit with Low Risk
12/10/2018 | Author: Francoise A. Marvel, MD and Roger S. Blumenthal, MD | Atherosclerotic cardiovascular disease (ASCVD) continue...
Genetic Architecture of Congenital Heart Disease: An Update and Future Challenge
09/27/2018 | Author: Maria Grazia Andreassi, MSc, PhD | Congenital heart disease (CHD), with an estimated incidence of 2-3% when b...
Cardiovascular Health in Turner Syndrome - No Small Task
09/24/2018 | Author: Vaneeta Bamba, MD | Aortopathy is a significant cause of early morbidity and mortality in women with Turner S...
Tackling Resistant Hypertension - Opportunities and Challenges
09/13/2018 | Author: Rhian M Touyz MD, PhD | Patients with resistant hypertension are at greater risk of cardiovascular events wit...
It's Time to Get With The Guidelines: The AHA Scientific Statement in Support of
09/04/2018 | Author: Zachary K. Wegermann, MD and Sunil V. Rao, MD | It?s Time to Get With The Guidelines: The AHA Scientific Stat...